Join a Clinical Trial

The Society for Women’s Health Research (SWHR) was founded to bring national attention to the problem of the exclusion of women from medical research and clinical trials and the need for greater federal funding for diseases and conditions prevalent in, and unique to women. Historically women had been left out of medical research studies because doctors and scientists did not believe there were important differences in how diseases affected men and women. These differences are now recognized as key factors in understanding how our bodies work and fight disease.

To help women find clinical trials in which they might like to participate, SWHR has begun to list trials that are recruiting women for various conditions. SWHR does not endorse or recommend any trial and is only providing the information as a service. Choosing to take part in a medical research study is a decision that you make with the help of family, friends, health care professionals, and others you trust and respect. Below you will find lists of clinical trials that need participants, the condition the trial is studying, who qualifies, and contact information for the research coordinators and investigators. Additional information about these trials and other clinical trials can be found at

Although we know more today and often take health advances for granted, much remains to be learned. Whether you have a disease or condition that needs treatment or are in perfect health, you can play an important role in improving health care. By volunteering to take part in a research study, you can make a valuable contribution to medical knowledge for your own health and the health of all future generations of women.

Need more information? Visit our Clinical Trials FAQ page.

Click to jump to a specific topic:

Alzheimer's Disease Studies Oral Treatment Studies
Breast Cancer Studies Pain Studies
Diet and Weight Studie
Sexual Health Studies
Heart Studies
Spina Bifida Studies
IBS Studies
Incontinence/Urology Studies

Alzheimer's Disease Studies:

The Studies Who Qualifies The Research Coordinators
ADNI GO is a landmark research study sponsored by the National Institute on Aging (NIA) at the National Institutes of Health (NIH). It is examining the sequence and timing of events at the initial onset of mild cognitive symptoms and may help scientists to better identify who is at risk for AD, as well as the effectiveness of potential prevention and treatment strategies. This two-year, $24 million study focuses for the first time on people experiencing the very earliest complaints of memory problems that affect their daily activities. ADNI GO expands on the groundbreaking Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest and most comprehensive study of its kind to date, and will continue efforts to identify biomarkers that can help build a greater understanding of the progression of AD. Please contact the research site in your area to see if you qualify. For a list of sites please visit the ADNI GO Study's website. Please visit the ADNI GO Study's website for a list of participating Clinical Study Research sites and their contact information.

Back to Top

Breast Cancer Studies: ( is a free, nonprofit, clinical trial matching service that can help you quickly and easily find breast cancer trials that might be right for you. has easy-to-read trial summaries and a secure message service for contacting participating research sites. You also can sign up for their trial alert service to learn about newly added trials that match your health history.

The Studies Who Qualifies The Research Coordinators
The XPAND Study. Evaluation of a needle free, patient controlled tissue expander. The goal of the XPAND study is to compare the AeroForm patient controlled tissue expander to traditional saline expanders used in breast reconstruction surgery. Measurements will include time to expansion and permanent implant exchange, pain and ease of use. Participants must be women 18-65 years old, requiring tissue expansion for breast reconstruction. Written consent will be required as will compliance with the study requirements. Participants cannot be smokers, have had prior surgery or radiation at the intended expansion site, are pregnant or have currently implanted electronic devices. Please visit (NCT01425268) for a list of participating sites and the corresponding study coordinator's contact information.

Back to Top

Diet and Weight Studies:

The Studies Who Qualifies The Research Coordinators
Effects of study medication for weight loss in men and women. Testing an FDA approved drug for the purpose of weight loss in obese individuals. Dietary counseling is included for all participants. Obese women and men who are committed to losing weight. Carol Mack at 202-293-1000

Back to Top

Heart Studies:

The Studies Who Qualifies The Research Coordinators
CABANA - Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation

This is a comparative randomized clinical trial for the treatment of Atrial Fibrillation. The intent of the CABANA trial is to enroll patients who have new onset or under-treated paroxysmal, persistent, or longstanding persistent atrial fibrillation and who warrant therapy for their arrhythmia.
Key Inclusion criteria
  1. >18 years of age.
  2. ECG-documented AF episodes >1 hour in duration.
  3. Eligible for catheter ablation and >2 sequential rhythm control and/or >3 rate control drugs.
  4. >65 yrs of age, or <65 yrs with at least one stroke risk factor: Hypertension, diabetes mellitus, prior stroke or TIA, congestive heart failure or LVEF <35%, or left atrial enlargement (> 5.0 cm).
Key Exclusion Criteria
  1. Lone AF in patients <65 years of age
  2. Patients who have failed >2 anti-arrhythmic drugs at a therapeutic dose due to inefficacy or side effects
  3. More than one week of amiodarone treatment in the past 3 months
  4. An efficacy failure of full dose amiodarone treatment >12 weeks duration at any time
  5. Reversible causes of AF including thyroid disorders, acute alcohol intoxication, recent major surgical procedures, or trauma
  6. Prior LA catheter ablation with the intention of treating AF
  7. Contraindication to warfarin anti-coagulation
The Arrhythmia Service at Johns Hopkins Medicine is currently recruiting for this trial under the direction of Dr. Hugh Calkins and Dr. Joseph Marine.
If your physician has determined that you have an abnormal heart rhythm called atrial fibrillation that requires treatment, please contact the Johns Hopkins Research Coordinator at for study information.

Visit the trial website. The study is registered on the clinical trials website.

Back to Top

IBS Studies:

The Studies Who Qualifies The Research Coordinators
A Placebo-Controlled Trial of Lyrica for Irritable Bowel Syndrome (IBS). This study involves one study visit, taking study drug or placebo for 12 weeks, and completion of a questionnaire at home every week for 12 weeks. Women and men over the age of 18-70 who have been diagnosed with irritable bowel syndrome (IBS). Annie Almazar at or 507-284-5010

Back to Top

Incontinence/Urology Studies:

The Studies Who Qualifies The Research Coordinators

Interstitial Cystitis and Bladder Pain Syndrome: An IC/BPS research study is currently being conducted for women between the ages of 18 and 75. The study is designed to see how well an investigational study medicine works at reducing moderate-to-severe IC/BPS pain.

Women between the ages of 18 and 75 who have IC/BPS. Clinical evidence of IC.  Have provided written informed consent.

Back to Top

Oral Treatment Studies:

The Studies Who Qualifies The Research Coordinators
Oral Treatment for Endometriosis and Associated Pain:
Purpose of study is to evaluate the safety and effectiveness of a new oral medication for the mangement of moderate to severe endometriosis-associated pain.
Participants must be premenopausal women between 18-49 years of age and have been surgically diagnosed with endometriosis within the past seven years.
Carol Mack at or 202-293-1000

Back to Top

Pain Studies:

The Studies Who Qualifies The Research Coordinators
Constipation from Prescription Opioid Pain Medicines:
If you regularly take a prescription opioid pain medicine, such as morphine, and also experience constipation, you may be eligible to participate in a clinical research study. AstraZeneca is sponsoring a clinical research study to determine whether an investigational drug is safe and effective to treat constipation as a side effect in people taking opioid pain medicines. The study may last up to 18 weeks with an option to continue in the long-term safety study.
Participants must be:
  • 18 or older and live in the United States;
  • Taking at least one prescription opioid pain medicine, every day for at least four weeks; and
  • Also experiencing constipation
For more information and to find out if you are eligible, please visit or call 1-866-320-6957

Back to Top

Schizophrenia Studies:

The Studies Who Qualifies The Research Coordinators
This study examines the role genes play in schizophrenia. Travel and lodging assistance may be available.

Recruiting ages 18-55. [95-M-0150]. 

Eligible participants have a diagnosis of schizophrenia and no serious drug or alcohol abuse.

If possible, the siblings and/or parents of the individuals are invited for interviews and blood donation.


Sexual Health Studies:

The Studies Who Qualifies The Research Coordinators
A Randomized, Double-Blind, Placebo-Controlled Research Study to Evaluate a Novel Vulvar Cream Containing Cutaneous Lysate for Provoked Vestibulodynia

Seeking Women in AZ, CA, DC, PA, & NY

Women between the ages of 20 and 55 who are not pregnant or breastfeeding may be eligible to participate in this study. Women must experience pain with tampon insertion and/or intercourse that affects their sexual function, and practice a reliable form of birth control. Those with a history of diabetes, heart disease, HIV, hepatitis B or C, or menopause are not eligible. Women must be able to attend two clinic visits, plus two telephone interviews, and complete all questionnaires in English over the course of the 12-week study. The study cream and other related study tests will be provided at no cost. Participating Centers:

The Centers for Vulvovaginal Disorders (Washington, DC)
Contact Hillary Tolson
Principal Investigator: Andrew T. Goldstein, MD

Pelvic & Sexual Health Institute (Philadelphia, PA)
Contact Elizabeth Elias, CCRC
Principal Investigator: Kristene Whitmore, MD
Co-Investigator: Susan Kellogg-Spadt, PhD, PA-C

San Diego Sexual Medicine (San Diego, CA)
Contact Margaret Carr
Principal Investigator: Irwin Goldstein, MD

Arizona Vulva Clinic (Phoenix, AZ)
Contact Gabrielle Rodriguez
Principal Investigator: Joseph Brooks, MD

New York Center for Women's Health Research (New York, NY)
Contact Lauren Pellegrino, WHNP-BE
Principal Investigator: Kenneth A. Levey, MD

Queen's Sexual Health Research Lab - The purpose of this study is to help determine the causes of and possible treatments for women's pain during intercourse.

There are several in-lab studies examining:

  • 2 non-medical treatments for genital pain
  • Genital pain sensitivity
  • Genital blood flow
  • Pain processing with brain imaging
  • Pelvic floor muscles with ultrasound imaging
  • Verbal interactions between couples

There are also several online studies for women with or without the above criteria.

Participants must be:
  • Females
  • 18 years or older
  • Experience pain during intercourse or have pain such as migraine headaches that cause arousal difficulties
For more information, please contact the Sexual Health Research Lab at or 613-533-3276

Back to Top

Spina Bifida Studies:

The Studies Who Qualifies The Research Coordinators
MOMS: Management of Myelomeningocele Study - to understand which treatment - postnatal or prenatal surgery - is more effective in treating those with the condition. Read More Participants must be 18 years and older. They must be pregnant women carrying a fetus diagnosed with myelomeningocele. See More Study Coordinator at or 1-866-275-6667

Back to Top

More Trials